Pharmac Notification: Decision to widen access to ticagrelor for people after minor stroke or high-risk TIA
- admin82291
- 6 days ago
- 1 min read
From the 1 November 2025, Pharmac will be widening access to ticagrelor, a blood-thinning medicine that helps prevent blood clots, for short-term use following a minor stroke or high-risk transient ischemic attack (TIA).
This change provides a funded option for people who can’t take clopidogrel because it doesn’t work for them or they’re allergic to it.
It follows the discontinuation of dipyridamole, another blood-thinning medicine that was sometimes used instead of clopidogrel.
More information about this change is available here
Ngā mihi,
Josh Wiles
Senior Therapeutic Group Manager/Team Leader
